nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—PGR—ovarian cancer	0.366	0.789	CbGaD
Mifepristone—ABCB1—ovarian cancer	0.0983	0.211	CbGaD
Mifepristone—ABCC1—Epirubicin—ovarian cancer	0.0452	0.123	CbGbCtD
Mifepristone—ABCC1—Paclitaxel—ovarian cancer	0.0446	0.121	CbGbCtD
Mifepristone—ABCC1—Docetaxel—ovarian cancer	0.0323	0.0875	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—ovarian cancer	0.024	0.0652	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.022	0.0598	CbGbCtD
Mifepristone—CYP3A7—Paclitaxel—ovarian cancer	0.022	0.0598	CbGbCtD
Mifepristone—ABCB1—Topotecan—ovarian cancer	0.0217	0.059	CbGbCtD
Mifepristone—CYP3A5—Paclitaxel—ovarian cancer	0.0165	0.0449	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0159	0.0432	CbGbCtD
Mifepristone—CYP3A7—Docetaxel—ovarian cancer	0.0159	0.0432	CbGbCtD
Mifepristone—ABCB1—Vinorelbine—ovarian cancer	0.0153	0.0415	CbGbCtD
Mifepristone—CYP2D6—Vinorelbine—ovarian cancer	0.0144	0.0391	CbGbCtD
Mifepristone—CYP3A4—Topotecan—ovarian cancer	0.013	0.0353	CbGbCtD
Mifepristone—CYP3A5—Docetaxel—ovarian cancer	0.012	0.0324	CbGbCtD
Mifepristone—ABCB1—Paclitaxel—ovarian cancer	0.0108	0.0292	CbGbCtD
Mifepristone—PGR—corpus luteum—ovarian cancer	0.0098	0.183	CbGeAlD
Mifepristone—CYP3A4—Vinorelbine—ovarian cancer	0.00918	0.0249	CbGbCtD
Mifepristone—ABCB1—Docetaxel—ovarian cancer	0.00778	0.0211	CbGbCtD
Mifepristone—PGR—ovarian follicle—ovarian cancer	0.00767	0.143	CbGeAlD
Mifepristone—CYP3A4—Paclitaxel—ovarian cancer	0.00645	0.0175	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—ovarian cancer	0.0058	0.0157	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—ovarian cancer	0.00547	0.0148	CbGbCtD
Mifepristone—CYP3A4—Docetaxel—ovarian cancer	0.00466	0.0126	CbGbCtD
Mifepristone—CYP3A4—Doxorubicin—ovarian cancer	0.00348	0.00943	CbGbCtD
Mifepristone—PGR—oviduct—ovarian cancer	0.00337	0.0629	CbGeAlD
Mifepristone—AR—oviduct—ovarian cancer	0.00268	0.0501	CbGeAlD
Mifepristone—PGR—myometrium—ovarian cancer	0.00108	0.0201	CbGeAlD
Mifepristone—AR—myometrium—ovarian cancer	0.000859	0.016	CbGeAlD
Mifepristone—PGR—epithelium—ovarian cancer	0.000846	0.0158	CbGeAlD
Mifepristone—PGR—uterine cervix—ovarian cancer	0.000839	0.0157	CbGeAlD
Mifepristone—ABCC1—myometrium—ovarian cancer	0.000815	0.0152	CbGeAlD
Mifepristone—PGR—decidua—ovarian cancer	0.000799	0.0149	CbGeAlD
Mifepristone—PGR—endometrium—ovarian cancer	0.000759	0.0142	CbGeAlD
Mifepristone—PGR—uterus—ovarian cancer	0.000699	0.0131	CbGeAlD
Mifepristone—AR—epithelium—ovarian cancer	0.000674	0.0126	CbGeAlD
Mifepristone—AR—uterine cervix—ovarian cancer	0.000668	0.0125	CbGeAlD
Mifepristone—AR—decidua—ovarian cancer	0.000637	0.0119	CbGeAlD
Mifepristone—ABCC1—uterine cervix—ovarian cancer	0.000635	0.0119	CbGeAlD
Mifepristone—PGR—female reproductive system—ovarian cancer	0.000628	0.0117	CbGeAlD
Mifepristone—NR3C1—myometrium—ovarian cancer	0.000622	0.0116	CbGeAlD
Mifepristone—ABCC1—decidua—ovarian cancer	0.000605	0.0113	CbGeAlD
Mifepristone—AR—endometrium—ovarian cancer	0.000604	0.0113	CbGeAlD
Mifepristone—NR3C1—embryo—ovarian cancer	0.000598	0.0112	CbGeAlD
Mifepristone—ABCC1—endometrium—ovarian cancer	0.000574	0.0107	CbGeAlD
Mifepristone—PGR—female gonad—ovarian cancer	0.000572	0.0107	CbGeAlD
Mifepristone—PGR—vagina—ovarian cancer	0.000568	0.0106	CbGeAlD
Mifepristone—AR—gonad—ovarian cancer	0.000561	0.0105	CbGeAlD
Mifepristone—AR—uterus—ovarian cancer	0.000557	0.0104	CbGeAlD
Mifepristone—ABCC1—uterus—ovarian cancer	0.000529	0.00988	CbGeAlD
Mifepristone—PGR—testis—ovarian cancer	0.000507	0.00947	CbGeAlD
Mifepristone—AR—female reproductive system—ovarian cancer	0.000501	0.00935	CbGeAlD
Mifepristone—NR3C1—epithelium—ovarian cancer	0.000488	0.00912	CbGeAlD
Mifepristone—CYP3A5—uterine cervix—ovarian cancer	0.000488	0.00911	CbGeAlD
Mifepristone—NR3C1—uterine cervix—ovarian cancer	0.000484	0.00904	CbGeAlD
Mifepristone—NR3C1—decidua—ovarian cancer	0.000461	0.00861	CbGeAlD
Mifepristone—AR—female gonad—ovarian cancer	0.000456	0.00851	CbGeAlD
Mifepristone—AR—vagina—ovarian cancer	0.000453	0.00846	CbGeAlD
Mifepristone—NR3C1—endometrium—ovarian cancer	0.000438	0.00818	CbGeAlD
Mifepristone—ABCC1—female gonad—ovarian cancer	0.000433	0.00808	CbGeAlD
Mifepristone—ABCC1—vagina—ovarian cancer	0.00043	0.00803	CbGeAlD
Mifepristone—NR3C1—gonad—ovarian cancer	0.000406	0.00758	CbGeAlD
Mifepristone—AR—testis—ovarian cancer	0.000404	0.00755	CbGeAlD
Mifepristone—NR3C1—uterus—ovarian cancer	0.000403	0.00753	CbGeAlD
Mifepristone—ABCC1—testis—ovarian cancer	0.000384	0.00717	CbGeAlD
Mifepristone—PGR—lymph node—ovarian cancer	0.000368	0.00687	CbGeAlD
Mifepristone—NR3C1—female reproductive system—ovarian cancer	0.000363	0.00677	CbGeAlD
Mifepristone—NR3C1—bone marrow—ovarian cancer	0.000342	0.00639	CbGeAlD
Mifepristone—ABCB1—myometrium—ovarian cancer	0.000333	0.00622	CbGeAlD
Mifepristone—CYP3A5—female gonad—ovarian cancer	0.000332	0.00621	CbGeAlD
Mifepristone—CYP3A5—vagina—ovarian cancer	0.00033	0.00617	CbGeAlD
Mifepristone—NR3C1—female gonad—ovarian cancer	0.00033	0.00616	CbGeAlD
Mifepristone—NR3C1—vagina—ovarian cancer	0.000328	0.00612	CbGeAlD
Mifepristone—ABCB1—embryo—ovarian cancer	0.00032	0.00598	CbGeAlD
Mifepristone—AR—lymph node—ovarian cancer	0.000293	0.00547	CbGeAlD
Mifepristone—NR3C1—testis—ovarian cancer	0.000293	0.00547	CbGeAlD
Mifepristone—ABCC1—lymph node—ovarian cancer	0.000278	0.0052	CbGeAlD
Mifepristone—CYP3A4—female reproductive system—ovarian cancer	0.000274	0.00512	CbGeAlD
Mifepristone—CYP2D6—female reproductive system—ovarian cancer	0.00027	0.00504	CbGeAlD
Mifepristone—ABCB1—epithelium—ovarian cancer	0.000261	0.00488	CbGeAlD
Mifepristone—ABCB1—uterine cervix—ovarian cancer	0.000259	0.00484	CbGeAlD
Mifepristone—ABCB1—decidua—ovarian cancer	0.000247	0.00461	CbGeAlD
Mifepristone—CYP2D6—female gonad—ovarian cancer	0.000246	0.00459	CbGeAlD
Mifepristone—ABCB1—endometrium—ovarian cancer	0.000234	0.00438	CbGeAlD
Mifepristone—CYP2D6—testis—ovarian cancer	0.000218	0.00407	CbGeAlD
Mifepristone—ABCB1—gonad—ovarian cancer	0.000217	0.00406	CbGeAlD
Mifepristone—ABCB1—uterus—ovarian cancer	0.000216	0.00403	CbGeAlD
Mifepristone—NR3C1—lymph node—ovarian cancer	0.000212	0.00396	CbGeAlD
Mifepristone—ABCB1—female reproductive system—ovarian cancer	0.000194	0.00363	CbGeAlD
Mifepristone—Chills—Paclitaxel—ovarian cancer	0.000188	0.00248	CcSEcCtD
Mifepristone—Hypersensitivity—Melphalan—ovarian cancer	0.000186	0.00247	CcSEcCtD
Mifepristone—Asthenia—Topotecan—ovarian cancer	0.000185	0.00245	CcSEcCtD
Mifepristone—Hot flush—Epirubicin—ovarian cancer	0.000185	0.00245	CcSEcCtD
Mifepristone—Vomiting—Chlorambucil—ovarian cancer	0.000184	0.00244	CcSEcCtD
Mifepristone—ABCB1—bone marrow—ovarian cancer	0.000183	0.00342	CbGeAlD
Mifepristone—Mental disorder—Paclitaxel—ovarian cancer	0.000183	0.00243	CcSEcCtD
Mifepristone—Menopausal symptoms—Epirubicin—ovarian cancer	0.000183	0.00243	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000183	0.00243	CcSEcCtD
Mifepristone—Pruritus—Topotecan—ovarian cancer	0.000183	0.00242	CcSEcCtD
Mifepristone—Malnutrition—Paclitaxel—ovarian cancer	0.000182	0.00241	CcSEcCtD
Mifepristone—Feeling abnormal—Vinorelbine—ovarian cancer	0.000182	0.00241	CcSEcCtD
Mifepristone—Asthenia—Melphalan—ovarian cancer	0.000181	0.0024	CcSEcCtD
Mifepristone—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000181	0.00239	CcSEcCtD
Mifepristone—Pruritus—Melphalan—ovarian cancer	0.000179	0.00237	CcSEcCtD
Mifepristone—Haemoglobin—Docetaxel—ovarian cancer	0.000178	0.00236	CcSEcCtD
Mifepristone—Haemorrhage—Docetaxel—ovarian cancer	0.000177	0.00235	CcSEcCtD
Mifepristone—Hypoglycaemia—Epirubicin—ovarian cancer	0.000177	0.00235	CcSEcCtD
Mifepristone—ABCB1—female gonad—ovarian cancer	0.000177	0.0033	CbGeAlD
Mifepristone—Diarrhoea—Topotecan—ovarian cancer	0.000177	0.00234	CcSEcCtD
Mifepristone—Back pain—Paclitaxel—ovarian cancer	0.000176	0.00233	CcSEcCtD
Mifepristone—ABCB1—vagina—ovarian cancer	0.000176	0.00328	CbGeAlD
Mifepristone—Urticaria—Vinorelbine—ovarian cancer	0.000175	0.00232	CcSEcCtD
Mifepristone—Muscle spasms—Paclitaxel—ovarian cancer	0.000175	0.00232	CcSEcCtD
Mifepristone—Abdominal pain—Vinorelbine—ovarian cancer	0.000175	0.00231	CcSEcCtD
Mifepristone—Body temperature increased—Vinorelbine—ovarian cancer	0.000175	0.00231	CcSEcCtD
Mifepristone—Oedema peripheral—Docetaxel—ovarian cancer	0.000175	0.00231	CcSEcCtD
Mifepristone—Connective tissue disorder—Docetaxel—ovarian cancer	0.000174	0.00231	CcSEcCtD
Mifepristone—Diarrhoea—Melphalan—ovarian cancer	0.000173	0.00229	CcSEcCtD
Mifepristone—Pain in extremity—Epirubicin—ovarian cancer	0.000173	0.00229	CcSEcCtD
Mifepristone—Nausea—Chlorambucil—ovarian cancer	0.000172	0.00228	CcSEcCtD
Mifepristone—Hot flush—Doxorubicin—ovarian cancer	0.000171	0.00226	CcSEcCtD
Mifepristone—Dizziness—Topotecan—ovarian cancer	0.000171	0.00226	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000169	0.00224	CcSEcCtD
Mifepristone—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000169	0.00224	CcSEcCtD
Mifepristone—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000169	0.00224	CcSEcCtD
Mifepristone—Angioedema—Paclitaxel—ovarian cancer	0.000166	0.0022	CcSEcCtD
Mifepristone—Vomiting—Topotecan—ovarian cancer	0.000164	0.00217	CcSEcCtD
Mifepristone—Malaise—Paclitaxel—ovarian cancer	0.000164	0.00217	CcSEcCtD
Mifepristone—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000164	0.00217	CcSEcCtD
Mifepristone—Rash—Topotecan—ovarian cancer	0.000163	0.00216	CcSEcCtD
Mifepristone—Hypersensitivity—Vinorelbine—ovarian cancer	0.000163	0.00216	CcSEcCtD
Mifepristone—Dermatitis—Topotecan—ovarian cancer	0.000163	0.00215	CcSEcCtD
Mifepristone—Headache—Topotecan—ovarian cancer	0.000162	0.00214	CcSEcCtD
Mifepristone—Angiopathy—Docetaxel—ovarian cancer	0.000161	0.00213	CcSEcCtD
Mifepristone—Vomiting—Melphalan—ovarian cancer	0.000161	0.00213	CcSEcCtD
Mifepristone—Pain in extremity—Doxorubicin—ovarian cancer	0.00016	0.00212	CcSEcCtD
Mifepristone—Mediastinal disorder—Docetaxel—ovarian cancer	0.00016	0.00212	CcSEcCtD
Mifepristone—Rash—Melphalan—ovarian cancer	0.000159	0.00211	CcSEcCtD
Mifepristone—Dermatitis—Melphalan—ovarian cancer	0.000159	0.00211	CcSEcCtD
Mifepristone—Chills—Docetaxel—ovarian cancer	0.000159	0.00211	CcSEcCtD
Mifepristone—Asthenia—Vinorelbine—ovarian cancer	0.000158	0.0021	CcSEcCtD
Mifepristone—Hypokalaemia—Epirubicin—ovarian cancer	0.000157	0.00208	CcSEcCtD
Mifepristone—Hypertension—Paclitaxel—ovarian cancer	0.000157	0.00208	CcSEcCtD
Mifepristone—ABCB1—testis—ovarian cancer	0.000157	0.00293	CbGeAlD
Mifepristone—Pruritus—Vinorelbine—ovarian cancer	0.000156	0.00207	CcSEcCtD
Mifepristone—Breast disorder—Epirubicin—ovarian cancer	0.000156	0.00207	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000156	0.00206	CcSEcCtD
Mifepristone—Mental disorder—Docetaxel—ovarian cancer	0.000155	0.00206	CcSEcCtD
Mifepristone—Arthralgia—Paclitaxel—ovarian cancer	0.000155	0.00205	CcSEcCtD
Mifepristone—Myalgia—Paclitaxel—ovarian cancer	0.000155	0.00205	CcSEcCtD
Mifepristone—Nasopharyngitis—Epirubicin—ovarian cancer	0.000154	0.00205	CcSEcCtD
Mifepristone—Anxiety—Paclitaxel—ovarian cancer	0.000154	0.00205	CcSEcCtD
Mifepristone—Malnutrition—Docetaxel—ovarian cancer	0.000154	0.00204	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000154	0.00204	CcSEcCtD
Mifepristone—Nausea—Topotecan—ovarian cancer	0.000153	0.00203	CcSEcCtD
Mifepristone—Discomfort—Paclitaxel—ovarian cancer	0.000153	0.00203	CcSEcCtD
Mifepristone—Muscular weakness—Epirubicin—ovarian cancer	0.000152	0.00202	CcSEcCtD
Mifepristone—Dry mouth—Paclitaxel—ovarian cancer	0.000152	0.00201	CcSEcCtD
Mifepristone—Diarrhoea—Vinorelbine—ovarian cancer	0.000151	0.002	CcSEcCtD
Mifepristone—Nausea—Melphalan—ovarian cancer	0.00015	0.00199	CcSEcCtD
Mifepristone—Back pain—Docetaxel—ovarian cancer	0.000149	0.00198	CcSEcCtD
Mifepristone—Oedema—Paclitaxel—ovarian cancer	0.000149	0.00197	CcSEcCtD
Mifepristone—Muscle spasms—Docetaxel—ovarian cancer	0.000148	0.00196	CcSEcCtD
Mifepristone—Infection—Paclitaxel—ovarian cancer	0.000148	0.00195	CcSEcCtD
Mifepristone—Dizziness—Vinorelbine—ovarian cancer	0.000146	0.00193	CcSEcCtD
Mifepristone—Nervous system disorder—Paclitaxel—ovarian cancer	0.000146	0.00193	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—ovarian cancer	0.000145	0.00193	CcSEcCtD
Mifepristone—Breast disorder—Doxorubicin—ovarian cancer	0.000144	0.00191	CcSEcCtD
Mifepristone—Skin disorder—Paclitaxel—ovarian cancer	0.000144	0.00191	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000144	0.00191	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000143	0.00189	CcSEcCtD
Mifepristone—Anorexia—Paclitaxel—ovarian cancer	0.000142	0.00188	CcSEcCtD
Mifepristone—Muscular weakness—Doxorubicin—ovarian cancer	0.000141	0.00187	CcSEcCtD
Mifepristone—Vomiting—Vinorelbine—ovarian cancer	0.00014	0.00186	CcSEcCtD
Mifepristone—Rash—Vinorelbine—ovarian cancer	0.000139	0.00184	CcSEcCtD
Mifepristone—Dermatitis—Vinorelbine—ovarian cancer	0.000139	0.00184	CcSEcCtD
Mifepristone—Hypotension—Paclitaxel—ovarian cancer	0.000139	0.00184	CcSEcCtD
Mifepristone—Headache—Vinorelbine—ovarian cancer	0.000138	0.00183	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000135	0.00179	CcSEcCtD
Mifepristone—Insomnia—Paclitaxel—ovarian cancer	0.000134	0.00178	CcSEcCtD
Mifepristone—Hypertension—Docetaxel—ovarian cancer	0.000133	0.00176	CcSEcCtD
Mifepristone—Infestation NOS—Epirubicin—ovarian cancer	0.000133	0.00176	CcSEcCtD
Mifepristone—Infestation—Epirubicin—ovarian cancer	0.000133	0.00176	CcSEcCtD
Mifepristone—Dyspnoea—Paclitaxel—ovarian cancer	0.000132	0.00175	CcSEcCtD
Mifepristone—Somnolence—Paclitaxel—ovarian cancer	0.000132	0.00175	CcSEcCtD
Mifepristone—Arthralgia—Docetaxel—ovarian cancer	0.000131	0.00174	CcSEcCtD
Mifepristone—Myalgia—Docetaxel—ovarian cancer	0.000131	0.00174	CcSEcCtD
Mifepristone—Nausea—Vinorelbine—ovarian cancer	0.000131	0.00174	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00013	0.00173	CcSEcCtD
Mifepristone—Decreased appetite—Paclitaxel—ovarian cancer	0.000129	0.00171	CcSEcCtD
Mifepristone—Dry mouth—Docetaxel—ovarian cancer	0.000128	0.0017	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000128	0.0017	CcSEcCtD
Mifepristone—Fatigue—Paclitaxel—ovarian cancer	0.000128	0.0017	CcSEcCtD
Mifepristone—Pain—Paclitaxel—ovarian cancer	0.000127	0.00168	CcSEcCtD
Mifepristone—Constipation—Paclitaxel—ovarian cancer	0.000127	0.00168	CcSEcCtD
Mifepristone—Oedema—Docetaxel—ovarian cancer	0.000126	0.00167	CcSEcCtD
Mifepristone—Infection—Docetaxel—ovarian cancer	0.000125	0.00166	CcSEcCtD
Mifepristone—Sinusitis—Epirubicin—ovarian cancer	0.000125	0.00165	CcSEcCtD
Mifepristone—Nervous system disorder—Docetaxel—ovarian cancer	0.000123	0.00164	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—ovarian cancer	0.000123	0.00163	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—ovarian cancer	0.000123	0.00163	CcSEcCtD
Mifepristone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000122	0.00162	CcSEcCtD
Mifepristone—Skin disorder—Docetaxel—ovarian cancer	0.000122	0.00162	CcSEcCtD
Mifepristone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000121	0.00161	CcSEcCtD
Mifepristone—Haemoglobin—Epirubicin—ovarian cancer	0.00012	0.00159	CcSEcCtD
Mifepristone—Anorexia—Docetaxel—ovarian cancer	0.00012	0.00159	CcSEcCtD
Mifepristone—Haemorrhage—Epirubicin—ovarian cancer	0.00012	0.00158	CcSEcCtD
Mifepristone—Urticaria—Paclitaxel—ovarian cancer	0.000118	0.00156	CcSEcCtD
Mifepristone—Oedema peripheral—Epirubicin—ovarian cancer	0.000118	0.00156	CcSEcCtD
Mifepristone—Hypotension—Docetaxel—ovarian cancer	0.000118	0.00156	CcSEcCtD
Mifepristone—Connective tissue disorder—Epirubicin—ovarian cancer	0.000117	0.00156	CcSEcCtD
Mifepristone—Abdominal pain—Paclitaxel—ovarian cancer	0.000117	0.00156	CcSEcCtD
Mifepristone—Body temperature increased—Paclitaxel—ovarian cancer	0.000117	0.00156	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—ovarian cancer	0.000116	0.00153	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000115	0.00152	CcSEcCtD
Mifepristone—Insomnia—Docetaxel—ovarian cancer	0.000114	0.00151	CcSEcCtD
Mifepristone—ABCB1—lymph node—ovarian cancer	0.000114	0.00212	CbGeAlD
Mifepristone—Dyspnoea—Docetaxel—ovarian cancer	0.000112	0.00149	CcSEcCtD
Mifepristone—Somnolence—Docetaxel—ovarian cancer	0.000112	0.00148	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—ovarian cancer	0.000111	0.00147	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—ovarian cancer	0.000111	0.00147	CcSEcCtD
Mifepristone—Decreased appetite—Docetaxel—ovarian cancer	0.000109	0.00145	CcSEcCtD
Mifepristone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000109	0.00145	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—ovarian cancer	0.000109	0.00144	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000109	0.00144	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000109	0.00144	CcSEcCtD
Mifepristone—Fatigue—Docetaxel—ovarian cancer	0.000109	0.00144	CcSEcCtD
Mifepristone—Angiopathy—Epirubicin—ovarian cancer	0.000108	0.00144	CcSEcCtD
Mifepristone—Mediastinal disorder—Epirubicin—ovarian cancer	0.000108	0.00143	CcSEcCtD
Mifepristone—Pain—Docetaxel—ovarian cancer	0.000108	0.00143	CcSEcCtD
Mifepristone—Constipation—Docetaxel—ovarian cancer	0.000108	0.00143	CcSEcCtD
Mifepristone—Chills—Epirubicin—ovarian cancer	0.000107	0.00142	CcSEcCtD
Mifepristone—Asthenia—Paclitaxel—ovarian cancer	0.000107	0.00141	CcSEcCtD
Mifepristone—Pruritus—Paclitaxel—ovarian cancer	0.000105	0.00139	CcSEcCtD
Mifepristone—Mental disorder—Epirubicin—ovarian cancer	0.000105	0.00139	CcSEcCtD
Mifepristone—Malnutrition—Epirubicin—ovarian cancer	0.000104	0.00138	CcSEcCtD
Mifepristone—Feeling abnormal—Docetaxel—ovarian cancer	0.000104	0.00137	CcSEcCtD
Mifepristone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000103	0.00136	CcSEcCtD
Mifepristone—Diarrhoea—Paclitaxel—ovarian cancer	0.000102	0.00135	CcSEcCtD
Mifepristone—Back pain—Epirubicin—ovarian cancer	0.000101	0.00133	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—ovarian cancer	0.0001	0.00133	CcSEcCtD
Mifepristone—Muscle spasms—Epirubicin—ovarian cancer	0.0001	0.00133	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—ovarian cancer	9.97e-05	0.00132	CcSEcCtD
Mifepristone—Abdominal pain—Docetaxel—ovarian cancer	9.95e-05	0.00132	CcSEcCtD
Mifepristone—Body temperature increased—Docetaxel—ovarian cancer	9.95e-05	0.00132	CcSEcCtD
Mifepristone—Chills—Doxorubicin—ovarian cancer	9.92e-05	0.00131	CcSEcCtD
Mifepristone—Dizziness—Paclitaxel—ovarian cancer	9.82e-05	0.0013	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—ovarian cancer	9.69e-05	0.00128	CcSEcCtD
Mifepristone—Ill-defined disorder—Epirubicin—ovarian cancer	9.65e-05	0.00128	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—ovarian cancer	9.63e-05	0.00128	CcSEcCtD
Mifepristone—Vomiting—Paclitaxel—ovarian cancer	9.44e-05	0.00125	CcSEcCtD
Mifepristone—Malaise—Epirubicin—ovarian cancer	9.38e-05	0.00124	CcSEcCtD
Mifepristone—Rash—Paclitaxel—ovarian cancer	9.36e-05	0.00124	CcSEcCtD
Mifepristone—Dermatitis—Paclitaxel—ovarian cancer	9.36e-05	0.00124	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—ovarian cancer	9.31e-05	0.00123	CcSEcCtD
Mifepristone—Headache—Paclitaxel—ovarian cancer	9.3e-05	0.00123	CcSEcCtD
Mifepristone—Hypersensitivity—Docetaxel—ovarian cancer	9.27e-05	0.00123	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—ovarian cancer	9.26e-05	0.00123	CcSEcCtD
Mifepristone—Asthenia—Docetaxel—ovarian cancer	9.03e-05	0.0012	CcSEcCtD
Mifepristone—Hypertension—Epirubicin—ovarian cancer	8.98e-05	0.00119	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—ovarian cancer	8.93e-05	0.00118	CcSEcCtD
Mifepristone—Pruritus—Docetaxel—ovarian cancer	8.91e-05	0.00118	CcSEcCtD
Mifepristone—Arthralgia—Epirubicin—ovarian cancer	8.86e-05	0.00117	CcSEcCtD
Mifepristone—Myalgia—Epirubicin—ovarian cancer	8.86e-05	0.00117	CcSEcCtD
Mifepristone—Anxiety—Epirubicin—ovarian cancer	8.83e-05	0.00117	CcSEcCtD
Mifepristone—Nausea—Paclitaxel—ovarian cancer	8.82e-05	0.00117	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	8.8e-05	0.00117	CcSEcCtD
Mifepristone—Discomfort—Epirubicin—ovarian cancer	8.75e-05	0.00116	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—ovarian cancer	8.68e-05	0.00115	CcSEcCtD
Mifepristone—Dry mouth—Epirubicin—ovarian cancer	8.66e-05	0.00115	CcSEcCtD
Mifepristone—Diarrhoea—Docetaxel—ovarian cancer	8.61e-05	0.00114	CcSEcCtD
Mifepristone—Oedema—Epirubicin—ovarian cancer	8.49e-05	0.00112	CcSEcCtD
Mifepristone—Infection—Epirubicin—ovarian cancer	8.44e-05	0.00112	CcSEcCtD
Mifepristone—Nervous system disorder—Epirubicin—ovarian cancer	8.33e-05	0.0011	CcSEcCtD
Mifepristone—Dizziness—Docetaxel—ovarian cancer	8.32e-05	0.0011	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—ovarian cancer	8.31e-05	0.0011	CcSEcCtD
Mifepristone—Skin disorder—Epirubicin—ovarian cancer	8.25e-05	0.00109	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—ovarian cancer	8.2e-05	0.00109	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—ovarian cancer	8.2e-05	0.00109	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—ovarian cancer	8.17e-05	0.00108	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	8.14e-05	0.00108	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—ovarian cancer	8.1e-05	0.00107	CcSEcCtD
Mifepristone—Anorexia—Epirubicin—ovarian cancer	8.09e-05	0.00107	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—ovarian cancer	8.02e-05	0.00106	CcSEcCtD
Mifepristone—Vomiting—Docetaxel—ovarian cancer	8e-05	0.00106	CcSEcCtD
Mifepristone—Rash—Docetaxel—ovarian cancer	7.94e-05	0.00105	CcSEcCtD
Mifepristone—Hypotension—Epirubicin—ovarian cancer	7.93e-05	0.00105	CcSEcCtD
Mifepristone—Dermatitis—Docetaxel—ovarian cancer	7.93e-05	0.00105	CcSEcCtD
Mifepristone—Headache—Docetaxel—ovarian cancer	7.89e-05	0.00104	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—ovarian cancer	7.86e-05	0.00104	CcSEcCtD
Mifepristone—Infection—Doxorubicin—ovarian cancer	7.81e-05	0.00103	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	7.74e-05	0.00102	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—ovarian cancer	7.7e-05	0.00102	CcSEcCtD
Mifepristone—Insomnia—Epirubicin—ovarian cancer	7.68e-05	0.00102	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—ovarian cancer	7.63e-05	0.00101	CcSEcCtD
Mifepristone—Dyspnoea—Epirubicin—ovarian cancer	7.57e-05	0.001	CcSEcCtD
Mifepristone—Somnolence—Epirubicin—ovarian cancer	7.55e-05	0.001	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—ovarian cancer	7.49e-05	0.000992	CcSEcCtD
Mifepristone—Nausea—Docetaxel—ovarian cancer	7.48e-05	0.000991	CcSEcCtD
Mifepristone—Decreased appetite—Epirubicin—ovarian cancer	7.38e-05	0.000978	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—ovarian cancer	7.34e-05	0.000973	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Epirubicin—ovarian cancer	7.33e-05	0.000971	CcSEcCtD
Mifepristone—Fatigue—Epirubicin—ovarian cancer	7.32e-05	0.00097	CcSEcCtD
Mifepristone—Constipation—Epirubicin—ovarian cancer	7.26e-05	0.000962	CcSEcCtD
Mifepristone—Pain—Epirubicin—ovarian cancer	7.26e-05	0.000962	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	7.16e-05	0.000948	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—ovarian cancer	7.11e-05	0.000941	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—ovarian cancer	7e-05	0.000928	CcSEcCtD
Mifepristone—Feeling abnormal—Epirubicin—ovarian cancer	7e-05	0.000927	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—ovarian cancer	6.98e-05	0.000925	CcSEcCtD
Mifepristone—Gastrointestinal pain—Epirubicin—ovarian cancer	6.94e-05	0.00092	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—ovarian cancer	6.83e-05	0.000905	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	6.78e-05	0.000899	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—ovarian cancer	6.77e-05	0.000897	CcSEcCtD
Mifepristone—Urticaria—Epirubicin—ovarian cancer	6.75e-05	0.000894	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—ovarian cancer	6.72e-05	0.00089	CcSEcCtD
Mifepristone—Pain—Doxorubicin—ovarian cancer	6.72e-05	0.00089	CcSEcCtD
Mifepristone—Abdominal pain—Epirubicin—ovarian cancer	6.71e-05	0.000889	CcSEcCtD
Mifepristone—Body temperature increased—Epirubicin—ovarian cancer	6.71e-05	0.000889	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—ovarian cancer	6.47e-05	0.000858	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—ovarian cancer	6.42e-05	0.000851	CcSEcCtD
Mifepristone—Hypersensitivity—Epirubicin—ovarian cancer	6.26e-05	0.000829	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—ovarian cancer	6.24e-05	0.000827	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—ovarian cancer	6.21e-05	0.000823	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—ovarian cancer	6.21e-05	0.000823	CcSEcCtD
Mifepristone—Asthenia—Epirubicin—ovarian cancer	6.09e-05	0.000807	CcSEcCtD
Mifepristone—Pruritus—Epirubicin—ovarian cancer	6.01e-05	0.000796	CcSEcCtD
Mifepristone—Diarrhoea—Epirubicin—ovarian cancer	5.81e-05	0.00077	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—ovarian cancer	5.79e-05	0.000767	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—ovarian cancer	5.64e-05	0.000747	CcSEcCtD
Mifepristone—Dizziness—Epirubicin—ovarian cancer	5.61e-05	0.000744	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—ovarian cancer	5.56e-05	0.000736	CcSEcCtD
Mifepristone—Vomiting—Epirubicin—ovarian cancer	5.4e-05	0.000715	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—ovarian cancer	5.38e-05	0.000712	CcSEcCtD
Mifepristone—Rash—Epirubicin—ovarian cancer	5.35e-05	0.000709	CcSEcCtD
Mifepristone—Dermatitis—Epirubicin—ovarian cancer	5.35e-05	0.000709	CcSEcCtD
Mifepristone—Headache—Epirubicin—ovarian cancer	5.32e-05	0.000705	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—ovarian cancer	5.2e-05	0.000688	CcSEcCtD
Mifepristone—Nausea—Epirubicin—ovarian cancer	5.04e-05	0.000668	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—ovarian cancer	5e-05	0.000662	CcSEcCtD
Mifepristone—Rash—Doxorubicin—ovarian cancer	4.95e-05	0.000656	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—ovarian cancer	4.95e-05	0.000656	CcSEcCtD
Mifepristone—Headache—Doxorubicin—ovarian cancer	4.92e-05	0.000652	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—ovarian cancer	4.67e-05	0.000618	CcSEcCtD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.73e-05	0.000725	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.7e-05	0.000716	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.68e-05	0.000712	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.66e-05	0.000705	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—ovarian cancer	2.64e-05	0.000699	CbGpPWpGaD
Mifepristone—AR—Gene Expression—YAP1—ovarian cancer	2.62e-05	0.000696	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPP1CC—ovarian cancer	2.61e-05	0.000691	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—BRIP1—ovarian cancer	2.61e-05	0.000691	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.6e-05	0.00069	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.6e-05	0.00069	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYTB—ovarian cancer	2.6e-05	0.000689	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	2.58e-05	0.000684	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—ESR1—ovarian cancer	2.54e-05	0.000674	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HDAC6—ovarian cancer	2.53e-05	0.000671	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.46e-05	0.000652	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.39e-05	0.000633	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HDAC6—ovarian cancer	2.36e-05	0.000625	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL6—ovarian cancer	2.35e-05	0.000624	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PGR—ovarian cancer	2.29e-05	0.000607	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.28e-05	0.000605	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—BRIP1—ovarian cancer	2.27e-05	0.000603	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPP1CC—ovarian cancer	2.27e-05	0.000603	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PPP2R1A—ovarian cancer	2.27e-05	0.000601	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.26e-05	0.000599	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—YAP1—ovarian cancer	2.24e-05	0.000594	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	2.23e-05	0.00059	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.22e-05	0.00059	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NME2—ovarian cancer	2.2e-05	0.000584	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.19e-05	0.000582	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—XIAP—ovarian cancer	2.19e-05	0.000582	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.18e-05	0.000579	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SMARCA4—ovarian cancer	2.14e-05	0.000567	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.13e-05	0.000566	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PARP1—ovarian cancer	2.13e-05	0.000565	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EREG—ovarian cancer	2.09e-05	0.000553	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.08e-05	0.000553	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NME2—ovarian cancer	2.07e-05	0.00055	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—IL6—ovarian cancer	2.06e-05	0.000547	CbGpPWpGaD
Mifepristone—ABCC1—Disease—XIAP—ovarian cancer	2.04e-05	0.000542	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SMARCA4—ovarian cancer	1.99e-05	0.000528	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—YAP1—ovarian cancer	1.99e-05	0.000528	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.97e-05	0.000523	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EREG—ovarian cancer	1.94e-05	0.000516	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	1.93e-05	0.000511	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.9e-05	0.000504	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYTB—ovarian cancer	1.88e-05	0.000498	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.84e-05	0.000489	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PARP1—ovarian cancer	1.82e-05	0.000482	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.78e-05	0.000473	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.76e-05	0.000467	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—YAP1—ovarian cancer	1.75e-05	0.000463	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PGR—ovarian cancer	1.74e-05	0.000461	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—ovarian cancer	1.73e-05	0.00046	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.73e-05	0.000459	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPP2R1A—ovarian cancer	1.73e-05	0.000458	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FASN—ovarian cancer	1.7e-05	0.000451	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PARP1—ovarian cancer	1.69e-05	0.000449	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPP1CC—ovarian cancer	1.64e-05	0.000436	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—BRIP1—ovarian cancer	1.64e-05	0.000436	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SLC2A1—ovarian cancer	1.62e-05	0.000429	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PARP1—ovarian cancer	1.62e-05	0.000428	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ESR1—ovarian cancer	1.61e-05	0.000426	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.53e-05	0.000406	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—YAP1—ovarian cancer	1.52e-05	0.000404	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.52e-05	0.000403	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PPP2R1A—ovarian cancer	1.47e-05	0.000391	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—FASN—ovarian cancer	1.42e-05	0.000378	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.42e-05	0.000377	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYTB—ovarian cancer	1.42e-05	0.000376	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.42e-05	0.000376	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC5A5—ovarian cancer	1.4e-05	0.000372	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.39e-05	0.000368	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.37e-05	0.000365	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PPP2R1A—ovarian cancer	1.37e-05	0.000364	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NME2—ovarian cancer	1.36e-05	0.00036	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC2A1—ovarian cancer	1.35e-05	0.000359	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.35e-05	0.000358	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.34e-05	0.000355	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYTB—ovarian cancer	1.34e-05	0.000354	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.32e-05	0.000351	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—ovarian cancer	1.32e-05	0.00035	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	1.31e-05	0.000348	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.3e-05	0.000346	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP1B1—ovarian cancer	1.3e-05	0.000344	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—FASN—ovarian cancer	1.24e-05	0.00033	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.24e-05	0.000329	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—BRIP1—ovarian cancer	1.24e-05	0.000329	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ESR1—ovarian cancer	1.22e-05	0.000324	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.22e-05	0.000324	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.18e-05	0.000313	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.18e-05	0.000313	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TERT—ovarian cancer	1.17e-05	0.000311	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.17e-05	0.00031	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.17e-05	0.00031	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.15e-05	0.000305	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.14e-05	0.000304	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.13e-05	0.0003	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.11e-05	0.000296	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—YAP1—ovarian cancer	1.1e-05	0.000292	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TERT—ovarian cancer	1.09e-05	0.000289	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.08e-05	0.000288	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CAV1—ovarian cancer	1.08e-05	0.000287	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ABCB1—ovarian cancer	1.07e-05	0.000283	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.06e-05	0.000281	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.06e-05	0.000281	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TYMS—ovarian cancer	1.05e-05	0.000278	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ESR1—ovarian cancer	1.04e-05	0.000277	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6ST—ovarian cancer	1.03e-05	0.000272	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CAV1—ovarian cancer	1.01e-05	0.000268	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1e-05	0.000266	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	1e-05	0.000266	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1e-05	0.000266	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APC—ovarian cancer	9.87e-06	0.000262	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CG—ovarian cancer	9.87e-06	0.000262	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6ST—ovarian cancer	9.57e-06	0.000254	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCB1—ovarian cancer	9.32e-06	0.000247	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR1—ovarian cancer	9.28e-06	0.000246	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.2e-06	0.000244	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APC—ovarian cancer	9.2e-06	0.000244	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TYMS—ovarian cancer	9.15e-06	0.000243	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—FASN—ovarian cancer	8.98e-06	0.000238	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.9e-06	0.000236	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC5A5—ovarian cancer	8.83e-06	0.000234	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYTB—ovarian cancer	8.74e-06	0.000232	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CD—ovarian cancer	8.67e-06	0.00023	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAPK3—ovarian cancer	8.58e-06	0.000228	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC2A1—ovarian cancer	8.53e-06	0.000226	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CAV1—ovarian cancer	8.45e-06	0.000224	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—ovarian cancer	8.35e-06	0.000221	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—YAP1—ovarian cancer	8.31e-06	0.00022	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP1B1—ovarian cancer	8.18e-06	0.000217	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CD—ovarian cancer	8.08e-06	0.000214	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.08e-06	0.000214	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—YAP1—ovarian cancer	7.83e-06	0.000208	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CG—ovarian cancer	7.7e-06	0.000204	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—ovarian cancer	7.66e-06	0.000203	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.64e-06	0.000203	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.64e-06	0.000203	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MTOR—ovarian cancer	7.56e-06	0.000201	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CB—ovarian cancer	7.56e-06	0.000201	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.52e-06	0.000199	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CAV1—ovarian cancer	7.37e-06	0.000196	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—ovarian cancer	7.26e-06	0.000193	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	7.25e-06	0.000192	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—ovarian cancer	7.14e-06	0.000189	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1B—ovarian cancer	7.09e-06	0.000188	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CB—ovarian cancer	7.05e-06	0.000187	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTOR—ovarian cancer	7.05e-06	0.000187	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—ovarian cancer	6.95e-06	0.000184	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—ovarian cancer	6.94e-06	0.000184	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—FASN—ovarian cancer	6.78e-06	0.00018	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CD—ovarian cancer	6.77e-06	0.00018	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—ovarian cancer	6.77e-06	0.00018	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCB1—ovarian cancer	6.74e-06	0.000179	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CG—ovarian cancer	6.72e-06	0.000178	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CTNNB1—ovarian cancer	6.7e-06	0.000178	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.67e-06	0.000177	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMS—ovarian cancer	6.61e-06	0.000175	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1B—ovarian cancer	6.61e-06	0.000175	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—ovarian cancer	6.57e-06	0.000174	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAPK3—ovarian cancer	6.54e-06	0.000173	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—ovarian cancer	6.53e-06	0.000173	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.44e-06	0.000171	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—FASN—ovarian cancer	6.39e-06	0.000169	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—ovarian cancer	6.36e-06	0.000169	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC5A5—ovarian cancer	6.28e-06	0.000167	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CTNNB1—ovarian cancer	6.25e-06	0.000166	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.17e-06	0.000164	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—ovarian cancer	6.09e-06	0.000161	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC2A1—ovarian cancer	6.07e-06	0.000161	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CD—ovarian cancer	5.9e-06	0.000157	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CB—ovarian cancer	5.9e-06	0.000157	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—ovarian cancer	5.9e-06	0.000156	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—ovarian cancer	5.84e-06	0.000155	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NRAS—ovarian cancer	5.83e-06	0.000155	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1B1—ovarian cancer	5.82e-06	0.000154	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—ovarian cancer	5.79e-06	0.000154	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK3—ovarian cancer	5.58e-06	0.000148	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.47e-06	0.000145	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—ovarian cancer	5.45e-06	0.000144	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NRAS—ovarian cancer	5.43e-06	0.000144	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—ovarian cancer	5.43e-06	0.000144	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CAV1—ovarian cancer	5.33e-06	0.000141	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK1—ovarian cancer	5.31e-06	0.000141	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—ovarian cancer	5.31e-06	0.000141	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK3—ovarian cancer	5.2e-06	0.000138	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	5.16e-06	0.000137	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CB—ovarian cancer	5.15e-06	0.000137	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—YAP1—ovarian cancer	5.12e-06	0.000136	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—ovarian cancer	5.1e-06	0.000135	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—ovarian cancer	5.06e-06	0.000134	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—ovarian cancer	5.02e-06	0.000133	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMS—ovarian cancer	4.99e-06	0.000132	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAPK3—ovarian cancer	4.96e-06	0.000132	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK1—ovarian cancer	4.95e-06	0.000131	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—ovarian cancer	4.95e-06	0.000131	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CG—ovarian cancer	4.86e-06	0.000129	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—ovarian cancer	4.83e-06	0.000128	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCB1—ovarian cancer	4.79e-06	0.000127	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMS—ovarian cancer	4.7e-06	0.000125	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—ovarian cancer	4.68e-06	0.000124	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—ovarian cancer	4.61e-06	0.000122	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—ovarian cancer	4.46e-06	0.000118	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—ovarian cancer	4.45e-06	0.000118	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—ovarian cancer	4.41e-06	0.000117	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—ovarian cancer	4.3e-06	0.000114	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CD—ovarian cancer	4.27e-06	0.000113	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—ovarian cancer	4.26e-06	0.000113	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—FASN—ovarian cancer	4.17e-06	0.000111	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.11e-06	0.000109	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—ovarian cancer	4.08e-06	0.000108	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CAV1—ovarian cancer	4.02e-06	0.000107	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—ovarian cancer	3.97e-06	0.000105	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.97e-06	0.000105	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—ovarian cancer	3.8e-06	0.000101	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.8e-06	0.000101	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CAV1—ovarian cancer	3.79e-06	0.000101	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—ovarian cancer	3.76e-06	9.99e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.72e-06	9.87e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.66e-06	9.72e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—ovarian cancer	3.6e-06	9.54e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—ovarian cancer	3.51e-06	9.31e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.45e-06	9.16e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.37e-06	8.94e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—ovarian cancer	3.35e-06	8.88e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.22e-06	8.54e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—ovarian cancer	3.21e-06	8.53e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—ovarian cancer	3.14e-06	8.32e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.13e-06	8.31e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMS—ovarian cancer	3.08e-06	8.16e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.03e-06	8.05e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—ovarian cancer	2.94e-06	7.79e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.81e-06	7.45e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.65e-06	7.02e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—ovarian cancer	2.56e-06	6.8e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CAV1—ovarian cancer	2.48e-06	6.57e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—ovarian cancer	2.43e-06	6.43e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—ovarian cancer	2.29e-06	6.06e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.27e-06	6.02e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.26e-06	5.99e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.98e-06	5.26e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—ovarian cancer	1.85e-06	4.91e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.73e-06	4.59e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.71e-06	4.54e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.61e-06	4.28e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—ovarian cancer	1.49e-06	3.96e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—ovarian cancer	1.4e-06	3.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—ovarian cancer	1.32e-06	3.49e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.05e-06	2.8e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—ovarian cancer	8.61e-07	2.28e-05	CbGpPWpGaD
